LEPR and hereditary disease: Setmelanotide is prescribed for the treatment of rare genetic diseases of obesity caused by certain variants of the genes encoding for pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) all of which cause a deficiency of these molecules [23].